Catalyst Pharmaceuticals, Inc.
2022 Q3 - 2025 Q4 (14 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/17/2026 | 114,626 | 1.5% | 4,911,161 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 98,003 | 1.5% | 4,974,767 | 9/30/2025 |
| 2025 Q2 | 8/14/2025 | 62,485 | 1.1% | 2,879,476 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 82,987 | 1.6% | 3,422,149 | 3/31/2025 |
| 2024 Q4 | 2/14/2025 | 65,386 | 1.2% | 3,133,011 | 12/31/2024 |
| 2024 Q3 | 11/14/2024 | 123,845 | 1.9% | 6,229,634 | 9/30/2024 |
| 2024 Q2 | 8/14/2024 | 141,382 | 2.4% | 9,127,305 | 6/30/2024 |
| 2024 Q1 | 5/15/2024 | 145,545 | 2.5% | 9,130,817 | 3/31/2024 |
| 2023 Q4 | 2/14/2024 | 149,422 | 2.8% | 8,888,901 | 12/31/2023 |
| 2023 Q3 | 11/14/2023 | 95,764 | 2.1% | 8,192,000 | 9/30/2023 |
| 2023 Q2 | 8/14/2023 | 110,100 | 2.4% | 8,192,000 | 6/30/2023 |
| 2023 Q1 | 5/15/2023 | 171,688 | 3.8% | 10,355,099 | 3/31/2023 |
| 2022 Q4 | 2/14/2023 | 109,451 | 2.3% | 5,884,448 | 12/31/2022 |
| 2022 Q3 | 11/14/2022 | 62,816 | 1.3% | 4,896,000 | 9/30/2022 |